Австралія - англійська - Department of Health (Therapeutic Goods Administration)

arjo australia pty ltd - 34488 - massager, electrical, bed/chair - the product provides sensory stimulation, by a comfortable rocking motion, musicure? music, the built-in bass vibration and the positioning and weight accessories. the intention of using the device is to decrease agitation, shouting, or aggressive behaviors, to obtain relaxation, to obtain increased arousal, to stimulate/obtain cognitive response, to stimulate and to improve overall well-being and quality of life for the patients/uses. the nordic sensi?chair can enhance a better, calmer and more pleasant working environment allowing a better quality of care. the target users of the device include all people with special needs including neuropsychological challenges who can benefit from using the chair, and healthy persons with the desire for relaxation.

США - англійська - myHealthbox

ecolab -

США - англійська - myHealthbox

ecolab -

Малайзія - англійська - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

fresenius medical care malaysia sdn bhd - calcium chloride dihydrate; sodium chloride.; magnesium chloride (hexahydrate); glucose monohydrate; sodium lactate solution -

Ізраїль - англійська - Ministry of Health

padagis israel agencies ltd, israel - rabies immunoglobulin - solution for injection - rabies immunoglobulin 150 iu/ml - rabies immunoglobulin - rabies immunoglobulin - to be given in conjunction with rabies vaccine as promptly as possible after exposure.

Канада - англійська - Health Canada

grifols therapeutics llc - rabies immunoglobulin (human) - solution - 150unit - rabies immunoglobulin (human) 150unit - serums

США - англійська - NLM (National Library of Medicine)

grifols usa, llc - human rabies virus immune globulin (unii: 95f619atq2) (human rabies virus immune globulin - unii:95f619atq2) - human rabies virus immune globulin 150 [iu] in 1 ml - rabies vaccine and hyperrab s/d should be given to all persons suspected of exposure to rabies with one exception: persons who have been previously immunized with rabies vaccine and have a confirmed adequate rabies antibody titer should receive only vaccine. hyperrab s/d should be administered as promptly as possible after exposure, but can be administered up to the eighth day after the first dose of vaccine is given. recommendations for use of passive and active immunization after exposure to an animal suspected of having rabies have been detailed by the u.s. public health service advisory committee on immunization practices (acip). [19] every exposure to possible rabies infection must be individually evaluated. the following factors should be considered before specific antirabies treatment is initiated: carnivorous wild animals (especially skunks, foxes, coyotes, raccoons, and bobcats) and bats are the animals most commonly infected with rabies and have caused most of the indigenous cases of human rabies

Канада - англійська - Health Canada

sanofi pasteur limited - rabies immunoglobulin (human) - solution - 150unit - rabies immunoglobulin (human) 150unit - serums

США - англійська - NLM (National Library of Medicine)

jubilant hollisterstier llc - bos taurus hair (unii: toq97z8644) (bos taurus hair - unii:toq97z8644), bos taurus dander (unii: c8vys726o8) (bos taurus dander - unii:c8vys726o8) - equus caballus hair 0.01 g in 1 ml - non-standardized allergenic extracts are indicated for: - skin test diagnosis of individuals with a clinical history of allergy to the specific corresponding allergens. non-standardized allergenic extracts are indicated for: - immunotherapy for the reduction of allergen-induced allergic symptoms confirmed by positive skin test or by in vitro testing for allergen specific ige antibodies for the specific corresponding allergens. non-standardized allergenic extracts are contraindicated in individuals with the following conditions: - severe, unstable or uncontrolled asthma. - history of any severe systemic reaction to the allergen extract when administered for diagnosis or treatment. - medical conditions that reduce the ability to survive anaphylaxis. risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes.  in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respecti

США - англійська - NLM (National Library of Medicine)

jubilant hollisterstier llc - populus deltoides pollen (unii: 476dvv63wp) (populus deltoides pollen - unii:476dvv63wp) - populus deltoides pollen 0.05 g in 1 ml - certain diagnostics carry labeling which states allergenic extract for diagnostic use only . data to support the therapeutic use of products labeled with this statement have not been established. 14 in addition to a carefully taken history, the use of glycerin-containing extracts in scratch, prick or puncture testing is an accepted method in the diagnosis of allergic conditions. 1, 2, 3 extracts of all allergens do not produce equivalent results in scratch, prick or puncture tests. the intensity of the skin reactions produced will be determined by two factors: the degree of sensitivity of the patient, and the nature of the allergenic extract applied. scratch, prick or puncture tests are not as sensitive as the intradermal test, but are safer and cause less discomfort. they may, therefore, be the method of choice when a large number of tests are needed, or when testing the pediatric patient. in some cases, where the relatively insensitive scratch, prick or puncture tests are negative or do not confirm the